CN101228110A - 3-[2-（二甲基氨基）甲基-（环己-1-基）]-苯酚马来酸盐及其结晶形式 - Google Patents

3-[2-（二甲基氨基）甲基-（环己-1-基）]-苯酚马来酸盐及其结晶形式 Download PDF

Info

Publication number
CN101228110A
CN101228110A CNA2006800267177A CN200680026717A CN101228110A CN 101228110 A CN101228110 A CN 101228110A CN A2006800267177 A CNA2006800267177 A CN A2006800267177A CN 200680026717 A CN200680026717 A CN 200680026717A CN 101228110 A CN101228110 A CN 101228110A
Authority
CN
China
Prior art keywords
methyl
dimethylamino
hexamethylene
crystal habit
phenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800267177A
Other languages
English (en)
Chinese (zh)
Inventor
M·格鲁斯
W·赫尔
M·塞拉吉维奇
J·伯格豪森
S·M·德波尔
M·冯劳默
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CN101228110A publication Critical patent/CN101228110A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CNA2006800267177A 2005-07-22 2006-07-20 3-[2-（二甲基氨基）甲基-（环己-1-基）]-苯酚马来酸盐及其结晶形式 Pending CN101228110A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005034974.9 2005-07-22
DE102005034974A DE102005034974A1 (de) 2005-07-22 2005-07-22 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen

Publications (1)

Publication Number Publication Date
CN101228110A true CN101228110A (zh) 2008-07-23

Family

ID=37084866

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800267177A Pending CN101228110A (zh) 2005-07-22 2006-07-20 3-[2-（二甲基氨基）甲基-（环己-1-基）]-苯酚马来酸盐及其结晶形式

Country Status (25)

Country Link
EP (1) EP1881956B1 (enExample)
JP (1) JP5205259B2 (enExample)
KR (1) KR20080033436A (enExample)
CN (1) CN101228110A (enExample)
AR (1) AR057674A1 (enExample)
AT (1) ATE431332T1 (enExample)
AU (1) AU2006271856B2 (enExample)
BR (1) BRPI0614057A2 (enExample)
CA (1) CA2615926A1 (enExample)
CY (1) CY1109208T1 (enExample)
DE (2) DE102005034974A1 (enExample)
DK (1) DK1881956T3 (enExample)
EC (1) ECSP088088A (enExample)
ES (1) ES2326493T3 (enExample)
HR (1) HRP20090412T1 (enExample)
IL (1) IL188897A (enExample)
MX (1) MX2008000743A (enExample)
NO (1) NO20080826L (enExample)
PE (1) PE20070368A1 (enExample)
PL (1) PL1881956T3 (enExample)
PT (1) PT1881956E (enExample)
RU (1) RU2434845C2 (enExample)
SI (1) SI1881956T1 (enExample)
WO (1) WO2007009792A1 (enExample)
ZA (1) ZA200801703B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI384986B (zh) * 2007-01-17 2013-02-11 Lg Life Sciences Ltd 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
PL2240431T3 (pl) * 2007-12-07 2017-07-31 Grünenthal GmbH Krystaliczne modyfikacje (1R,2R)-3-(3-dimetyloamino-1-etylo-2-metyIopropylo)fenoIu
EP2085081A1 (de) 2008-02-04 2009-08-05 Grünenthal GmbH 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10218862A1 (de) * 2002-04-26 2003-11-06 Gruenenthal Gmbh Verfahren zur Chlorierung tertiärer Alkohole
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen

Also Published As

Publication number Publication date
IL188897A0 (en) 2008-04-13
JP2009502757A (ja) 2009-01-29
ATE431332T1 (de) 2009-05-15
KR20080033436A (ko) 2008-04-16
PL1881956T3 (pl) 2009-10-30
AU2006271856A1 (en) 2007-01-25
EP1881956B1 (de) 2009-05-13
DE502006003728D1 (de) 2009-06-25
HRP20090412T1 (hr) 2009-09-30
RU2008106455A (ru) 2009-08-27
NO20080826L (no) 2008-02-20
PT1881956E (pt) 2009-06-26
DK1881956T3 (da) 2009-09-07
DE102005034974A1 (de) 2007-04-19
CY1109208T1 (el) 2014-07-02
WO2007009792A1 (de) 2007-01-25
BRPI0614057A2 (pt) 2012-12-11
ZA200801703B (en) 2009-08-26
AR057674A1 (es) 2007-12-12
HK1112612A1 (zh) 2008-09-12
MX2008000743A (es) 2008-03-10
IL188897A (en) 2012-12-31
RU2434845C2 (ru) 2011-11-27
SI1881956T1 (sl) 2009-10-31
ES2326493T3 (es) 2009-10-13
JP5205259B2 (ja) 2013-06-05
PE20070368A1 (es) 2007-05-12
CA2615926A1 (en) 2007-01-25
AU2006271856B2 (en) 2012-03-01
ECSP088088A (es) 2008-02-20
EP1881956A1 (de) 2008-01-30

Similar Documents

Publication Publication Date Title
US7750051B2 (en) Crystalline solid rasagiline base
US8334409B2 (en) Process for purifying rasagiline base
US9062047B2 (en) Crystalline form of pyrimido[6,1-A] isoquinolin-4-one compound
CN104230730A (zh) L-鸟氨酸苯乙酸盐及其制备方法
EP2909191A1 (en) Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
CN103570621B (zh) 一种（-）-石杉碱甲的制备
CN101228110A (zh) 3-[2-（二甲基氨基）甲基-（环己-1-基）]-苯酚马来酸盐及其结晶形式
JP2024500665A (ja) ２－ヒドロキシ－５－［２－（４－（トリフルオロメチルフェニル）エチルアミノ）］安息香酸結晶形およびこの製造方法
CN116969898A (zh) 一种和厚朴酚-川芎嗪共晶的制备方法
CN105384730A (zh) 依帕列净的晶型及其制备方法、药物组合物和用途
EA030553B1 (ru) Тапентадола малеат и его кристаллические формы
US20120178809A1 (en) Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
CN105017120B (zh) 依折麦布与烟酰胺药物共晶及其制备方法
JP2022540275A (ja) テトラメチルピラジンニトロンの結晶形、製造方法及び使用
WO2015043404A1 (zh) (-)-石杉碱甲盐
US20070032551A1 (en) Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
HK1112612B (en) 3-(2-(dimethylamino)methyl(cyclohex-1-yl))phenol maleate and its crystalline forms
CN105001138A (zh) 依折麦布与顺丁烯二酸药物共晶及其制备方法
NZ564902A (en) 3-[2-(Dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate and the crystalline forms thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20080723